DE1411025U - - Google Patents

Info

Publication number
DE1411025U
DE1411025U DENDAT1411025D DE1411025DU DE1411025U DE 1411025 U DE1411025 U DE 1411025U DE NDAT1411025 D DENDAT1411025 D DE NDAT1411025D DE 1411025D U DE1411025D U DE 1411025DU DE 1411025 U DE1411025 U DE 1411025U
Authority
DE
Germany
Prior art keywords
quot
lfr1í
prr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1411025D
Other languages
German (de)
English (en)
Publication of DE1411025U publication Critical patent/DE1411025U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DENDAT1411025D Active DE1411025U (enExample)

Publications (1)

Publication Number Publication Date
DE1411025U true DE1411025U (enExample)

Family

ID=721444

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1411025D Active DE1411025U (enExample)

Country Status (1)

Country Link
DE (1) DE1411025U (enExample)

Similar Documents

Publication Publication Date Title
Gould et al. Virulent Newcastle disease in Australia: molecular epidemiological analysis of viruses isolated prior to and during the outbreaks of 1998–2000
Nestorowicz et al. Molecular analysis of the hemagglutinin genes of Australian H7N7 influenza viruses: role of passerine birds in maintenance or transmission?
Greck et al. Electrophilic amination: New synthetic applications
YU18593A (sh) Sredstva protiv gljivičnih oboljenja koja sadrže ciklični peptid i postupak za njihovo dobijanje
SE9604341D0 (sv) Hepta-peptide oxytocin analogue
IT1274782B (it) Metodo per selezionare superagonisti, antagonisti e superantagonisti di ormoni del cui complesso recettoriale fa parte gp 130
US20020037860A1 (en) Method for reducing or preventing the establishment, growth or metastasis of cancer by administering indazole peptidomimetics PAR-1 antagonist and optionally PAR-2 antagonists
HU205146B (en) Process for producing teicoplanine amide derivatives and pharmaceutical compositions comprising same
DE60132177T2 (de) Aminosäure-derivate als hiv aspartyl-protease-inhibitoren
DE1411025U (enExample)
CZ23397A3 (en) Derivatives of parathormone and parathormone related peptide, process of their preparation and pharmaceutical compositions containing thereof
JP2001524083A (ja) テイコプラニン誘導体
CY1105796T1 (el) Θepαπεια οξεωσης της μεγαλης κοιλιας των μηρυκαστικων με αναστολεις αλφα-αμυλασης
Lin et al. Solid-phase synthesis of peptidomimetic oligomers with a phosphodiester backbone
HILL et al. Synthetic DNA probes for the identification of sibling species in the Anopheles gambiae complex
Toda et al. Regional and species differences in the response of isolated arteries to angiotensin II
JPH069628A (ja) ヒドロキシエチレン等量型のジチオラニルグリシン−含有hivプロテアーゼインヒビター
Van Berlo et al. Intracellular equine arteritis virus (EAV)-specific RNAs contain common sequences
CN101448850B (zh) 免疫调节寡肽
Awata et al. Assignment of the tenascin gene (HXB) to swine chromosome 1q21. 1→ q21. 3 by fluorescence in situ hybridization
Aiglstorfer et al. NPY Y1 antagonists: structure–activity relationships of arginine derivatives and hybrid compounds with arpromidine-like partial structures
Ball The responses of different strains of Eimeria acervulina and Eimeria tenella to medication
EP0183245A3 (en) Animal growth promotant
JPS63101398A (ja) オリゴペプチド抗生物質及びその製造方法並びに該抗生物質を含有する医薬
NO860624L (no) Acylerte heksosederivater og fremgangsmaater til fremstilling derav.